Technology area: Biotechnology & Pharmaceuticals
41 pending office actions • 36 art units • 40 examiners • 0 of 41 (0%) have an AI response strategy ready • 32 patents granted in the last 365 days
Ramot At Tel-aviv University Ltd. has 42 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 41 distinct examiners and 37 distinct art units, demonstrating broad examination coverage with some repeated examiner and art-unit assignments.
LEONARD, ARTHUR S is the busiest examiner, with 2 pending matters. The portfolio size supports centralized monitoring of recurring biotechnology issues, disclosure support, and claim strategies, but the broad distribution requires separate review of examiner practice and art-unit context for each matter.
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (10%) |
| §103 only | 9 (22%) |
| §102 only | 2 (5%) |
| §112 only | 4 (10%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 3 (7%) |
| Multi-statute (no §101) | 18 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEONARD, ARTHUR S | 2 | 50.5% | +50.4% |
| YANG, JEFFREY ANDREW | 1 | 87.5% | +23.2% |
| SHAH, UTPAL D | 1 | 87.8% | +11.4% |
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
| LEBOEUF, JEROME LARRY | 1 | 85.5% | +6.3% |
| MEADOWS, CHRISTINA L | 1 | 74.3% | +25.2% |
| COLEMAN, BRENDA LIBBY | 1 | 74.8% | +15.7% |
| BEG, SAMAH A | 1 | 78.1% | +32.0% |
| ROMERO, KRISTEN WANG | 1 | 69.8% | +30.8% |
| GAMBLE JR, RANDALL LEE | 1 | 51.3% | +26.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | — |
| 19032064 | SYSTEM AND METHOD FOR IDENTIFYING A PERSON IN A VIDEO | SHAH, UTPAL D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17257764 | METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION | MIDDLETON, DANAYA L | 99d overdue |
| 17628148 | DEVICE AND METHODS FOR TISSUE MOLECULAR PROFILING USING ELECTROPORATION BASED MOLECULAR EXTRACTION | FERNANDEZ, SUSAN EMILY | 45d overdue |
| 17780536 | COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM | SMITH, JEREMIAH R | 42d overdue |
| 18122194 | METHODS OF TREATING GLIOBLASTOMA | AEDER, SEAN E | 30d overdue |
| 18869977 | CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS | LEBOEUF, JEROME LARRY | 21d |
| 18021577 | MRI IN AN INHOMOGENEOUS FIELD WITH NO PULSED GRADIENTS | CRUZ, IRIANA | 56d |
| 18310044 | GATA6-AS1 lncRNA FOR USE IN THERAPY | GROOMS, TIFFANY NICOLE | 70d |
| 18876444 | RUST DISEASE RESISTANCE GENES AND USE THEREOF | DELEO, VICTORIA LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18768074 | ELECTROCHEMICAL DETECTION OF A VIRAL INFECTION | GAMBLE JR, RANDALL LEE | 17d overdue |
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | — |
| 19032064 | SYSTEM AND METHOD FOR IDENTIFYING A PERSON IN A VIDEO | SHAH, UTPAL D | — |
| 18855815 | SYSTEMS AND METHODS FOR GENOME-SCALE TARGETING OF FUNCTIONAL REDUNDANCY IN PLANTS | MEADOWS, CHRISTINA L | — |
| 18851760 | COMPOUNDS USABLE AS MODULATORS OF PERK ACTIVITY | COLEMAN, BRENDA LIBBY | — |
| 18704168 | A MACHINE VISION SYSTEM FOR LARVAL AQUATIC ANIMAL REARING | BEG, SAMAH A | — |
| 18768262 | COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ROMERO, KRISTEN WANG | — |
| 18123413 | METHOD AND SYSTEM FOR DESIGNING POLYNUCLEOTIDE SEQUENCES AND POLYNUCLEOTIDE SEQUENCES OBTAINED THEREBY | LEONARD, ARTHUR S | — |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 3791 | 2 |
| 1674 | 2 |
| 1631 | 2 |
| 1675 | 2 |
| 2111 | 1 |
| 2668 | 1 |
| 1662 | 1 |
| 2824 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | 2111 | §103 | Non-Final OA | — | Pending | Mar 06, 2025 |
| 19032064 | SYSTEM AND METHOD FOR IDENTIFYING A PERSON IN A VIDEO | SHAH, UTPAL D | 2668 | DP | Non-Final OA | — | Pending | Jan 19, 2025 |
| 18876444 | RUST DISEASE RESISTANCE GENES AND USE THEREOF | DELEO, VICTORIA LYNN | 1662 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18869977 | CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS | LEBOEUF, JEROME LARRY | 2824 | §103§112 | Final Rejection | 21d | Pending | Nov 27, 2024 |
| 18855815 | SYSTEMS AND METHODS FOR GENOME-SCALE TARGETING OF FUNCTIONAL REDUNDANCY IN PLANTS | MEADOWS, CHRISTINA L | 1663 | §102§103§112DP | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18851760 | COMPOUNDS USABLE AS MODULATORS OF PERK ACTIVITY | COLEMAN, BRENDA LIBBY | 1624 | §102§112DP | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18704168 | A MACHINE VISION SYSTEM FOR LARVAL AQUATIC ANIMAL REARING | BEG, SAMAH A | 2676 | §103 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18768262 | COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ROMERO, KRISTEN WANG | 1624 | §103§112 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18768074 | ELECTROCHEMICAL DETECTION OF A VIRAL INFECTION | GAMBLE JR, RANDALL LEE | 1795 | §103 | Final Rejection | 17d overdue | Pending | Jul 10, 2024 |
| 18719323 | TMS PROTOCOL AND ASSESSMENT | REDDY, SUNITA | 3791 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18718925 | NAP FOR SEX-SPECIFIC TREATMENT OF DISEASES | SCHWECHTER, BRANDON ROSS | 1674 | §102§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18674990 | METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY | COUGHLIN, DANIEL F | 1619 | §102Other | Non-Final OA | — | Pending | May 27, 2024 |
| 18710002 | FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §102§112 | Non-Final OA | — | Pending | May 14, 2024 |
| 18694614 | CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF | FETTEROLF, BRANDON J | 1626 | §112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18419732 | DIGITAL MICROFLUIDICS-LIKE MANIPULATION OF ELECTROKINETICALLY PRECONCENTRATED BIOPARTICLE/BIOMOLECULE PLUGS IN CONTINUOUS-FLOW | HERBERT, MADISON TAYLOR | 1758 | §102§103§112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18573517 | COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS | LIEB, JEANETTE M | 1654 | §103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18563892 | ANOMALY DETECTION FOR TABULAR DATA WITH INTERNAL CONTRASTIVE LEARNING | KEATON, SHERROD L | 2148 | §103Other | Non-Final OA | — | Pending | Nov 23, 2023 |
| 18382511 | DETUNING-MODULATED UNIVERSAL COMPOSITE GATES | PARIHAR, SUCHIN | 2851 | §102 | Non-Final OA | — | Pending | Oct 22, 2023 |
| 18235392 | MODULATORS OF PD-L1/PD-1 INTERACTION AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | 1621 | §102§112 | Final Rejection | — | Pending | Aug 18, 2023 |
| 18366403 | HUMAN ORAL MUCOSA STEM CELL SECRETOME | TATGE, LEXUS MARC | 1638 | §102§112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18038534 | OPTIMIZED WOUND SITE OFFLOADING FOOTWEAR | MARMOR II, CHARLES ALAN | 3791 | §103 | Final Rejection | 121d overdue | Pending | May 24, 2023 |
| 18310044 | GATA6-AS1 lncRNA FOR USE IN THERAPY | GROOMS, TIFFANY NICOLE | 1637 | §101§103§112 | Non-Final OA | 70d | Pending | May 01, 2023 |
| 18123413 | METHOD AND SYSTEM FOR DESIGNING POLYNUCLEOTIDE SEQUENCES AND POLYNUCLEOTIDE SEQUENCES OBTAINED THEREBY | LEONARD, ARTHUR S | 1631 | §102§103§112 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18122194 | METHODS OF TREATING GLIOBLASTOMA | AEDER, SEAN E | 1642 | §103§112 | Non-Final OA | 30d overdue | Pending | Mar 16, 2023 |
| 18021577 | MRI IN AN INHOMOGENEOUS FIELD WITH NO PULSED GRADIENTS | CRUZ, IRIANA | 2681 | §102§103 | Non-Final OA | 56d | Pending | Feb 16, 2023 |
| 18102800 | SENSING ELECTRODE AND METHOD OF FABRICATING THE SAME | EVANISKO, GEORGE ROBERT | 3792 | §102§103§112Other | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18002251 | COMPOSITIONS COMPRISING AROMATIC DIPEPTIDES-BASED STRUCTURES ENCAPSULATING AN ESTERASE AND USES THEREOF | RAMIREZ, DELIA M | 1652 | §103§112Other | Final Rejection | — | Pending | Dec 16, 2022 |
| 17921035 | CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME | HOLLAND, PAUL J | 1656 | §112 | Final Rejection | 13d | Pending | Oct 24, 2022 |
| 17783276 | BACTERIA-ASSOCIATED VOLATILE ORGANIC COMPOUNDS | BOECKELMAN, JACOB A | 1655 | §101§112 | Final Rejection | — | Pending | Jun 08, 2022 |
| 17780536 | COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM | SMITH, JEREMIAH R | 1723 | §102§103 | Non-Final OA | 42d overdue | Pending | May 27, 2022 |
| 17637682 | METHODS AND COMPOSITIONS FOR TREATING PAX6-DEFICIENCY RELATED DISEASE | PATTERSON, SARAH COOPER | 1675 | §112 | Final Rejection | — | Pending | Feb 23, 2022 |
| 17628148 | DEVICE AND METHODS FOR TISSUE MOLECULAR PROFILING USING ELECTROPORATION BASED MOLECULAR EXTRACTION | FERNANDEZ, SUSAN EMILY | 1651 | §103§112 | Non-Final OA | 45d overdue | Pending | Jan 18, 2022 |
| 17486936 | METHODS FOR MODIFYING TRANSLATION | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §101§103§112 | Non-Final OA | — | Pending | Sep 28, 2021 |
| 17399207 | MOLECULAR SENSOR BASED ON VIRTUAL BURIED NANOWIRE | CHIN, CHRISTOPHER L | 1677 | §112DP | Final Rejection | — | Pending | Aug 11, 2021 |
| 17345248 | INTEGRATED DRUG DISCOVERY PLATFORM FOR INBORN ERROR OF METABOLISM DISORDERS | MACFARLANE, STACEY NEE | 1675 | §103 | Non-Final OA | — | Pending | Jun 11, 2021 |
| 17257764 | METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION | MIDDLETON, DANAYA L | 1674 | §103§112 | Non-Final OA | 99d overdue | Pending | Jan 04, 2021 |
| 16959878 | TRANSGENIC EUKARYOTIC ORGANISMS AND METHODS FOR GENDER SELECTION | LEONARD, ARTHUR S | 1631 | §103 | Final Rejection | — | Pending | Jul 02, 2020 |
| 16588208 | DIAGNOSTIC METHODS AND KITS FOR EARLY DETECTION OF OVARIAN CANCER | LU, FRANK WEI MIN | 1683 | §112 | Final Rejection | 147d overdue | Pending | Sep 30, 2019 |
| 18570211 | MULTI-LAYERED MODULAR ORGAN-ON-A-CHIP PLATFORM | CARREON, ADRIAN JOHN | 1799 | §103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18110934 | ENGINEERED PROTEIN DELIVERY PLATFORM AND USE THEREOF FOR ANTIBACTERIAL TREATMENTS | KANE, TREVOR LOGAN | 1657 | §103§112Other | Final Rejection | — | Pending | Feb 17, 2023 |
| 18106009 | CASPOFUNGIN DERIVATIVES AND ASSAYS FOR EVALUATING ANTIFUNGAL TREATMENT EFFICACY | FISCHER, JOSEPH | 1658 | §102§112 | Non-Final OA | — | Pending | Feb 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRamot At Tel-aviv University Ltd. has 41 pending office actions as of October 2026, spread across 36 art units and 40 examiners.
Arthur S Leonard has the most, with 2 of Ramot At Tel-aviv University Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
